In NSCLC, IL-10 overproduction at the tumor site has been implicated in tumor-mediated immunosuppression, enhanced angiogenesis and serum IL-10 appears to be an indicator of poor prognosis (14). The gene discussed is IL10; the disease is non-small cell lung carcinoma.